Phenotype of limited cutaneous systemic sclerosis patients with positive anti-topoisomerase I antibodies: data from the EUSTAR cohort.

Elisabetta ZanattaDörte HuscherAugusta OrtolanJérôme AvouacPaolo AiròAlexandra Balbir-GurmanElise SiegertMarco Matucci CerinicFranco CozziGabriela RiemekastenAnna-Maria Hoffmann-VoldOliver DistlerArmando GabrielliStefan HeitmannNicolas HunzelmannCarlomaurizio MontecuccoJadranka Morovic-VerglesCamillo Ribi Andrea DoriaYannick Allanorenull null

Published in: Rheumatology (Oxford, England) (2022)

ATA-lcSSc patients have a high risk of ILD, albeit with a lower risk of progression compared with ATA-dcSSc, supporting careful screening for ILD in this subgroup.

Keyphrases

interstitial lung disease
systemic sclerosis
end stage renal disease
ejection fraction
rheumatoid arthritis
chronic kidney disease
newly diagnosed
idiopathic pulmonary fibrosis
peritoneal dialysis
electronic health record
machine learning
big data
deep learning